Health ❯ Medicine

Oncology

Cancer Research Cancer Treatment Breast Cancer Brain Cancer Cancer Pancreatic Cancer Chemotherapy Cancer Biology Prostate Cancer Colorectal Cancer

Innovations in Oncology

Venetoclax findings, psilocybin research, and nerve damage prevention

3 ARTICLES

17h ago

Venetoclax Reduces Intact SIV Reservoir in Macaques

The finding suggests BCL-2 blockade can shrink the long-lived viral reservoir, which could change HIV-cure strategies and is now being tested in people.

4 ARTICLES

22h ago

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

Stories older than 24h

9 ARTICLES

5d ago

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

7 ARTICLES

last wk.

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

9 ARTICLES

last wk.

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

3 ARTICLES

last wk.

Study Finds Estrogen Receptor Levels Form a Continuous Spectrum in HER2‑Negative Breast Cancer

21 ARTICLES

last wk.

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

5 ARTICLES

2w ago

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

3 ARTICLES

3w ago

Receptor Pathway Lets Antisense Drugs Escape Endosomes to Silence KRAS in Pancreatic Cancer

3 ARTICLES

4w ago

Dana-Farber Reports Metabolically Activated Molecular Glue and New Discovery Platform

14 ARTICLES

4w ago

Algae-Based Microrobots Greatly Increase Chemotherapy Delivery to Bladder Tumors

3 ARTICLES

2mo ago

Fibroblasts Explain Why Lung Cancer Subtypes Respond Differently to Anti‑Angiogenic Drugs

Oncology

Venetoclax Reduces Intact SIV Reservoir in Macaques

Psilocybin Prevents Chemotherapy Nerve Damage in Mice

FDA Approves First Broad RAS Inhibitor for Metastatic Pancreatic Cancer

Moderna and Merck Report Positive Phase 3 Result for Personalized mRNA Melanoma Vaccine

FDA Approves Rasonque, an Oral KRAS Inhibitor, for Metastatic Pancreatic Cancer

Study Finds Estrogen Receptor Levels Form a Continuous Spectrum in HER2‑Negative Breast Cancer

Moderna and Merck Say Phase 3 Personalized mRNA Melanoma Vaccine Met Key Endpoints

Moderna and Merck Personalized mRNA Vaccine Cuts Melanoma Recurrence in Phase 3 Readout

Receptor Pathway Lets Antisense Drugs Escape Endosomes to Silence KRAS in Pancreatic Cancer

Dana-Farber Reports Metabolically Activated Molecular Glue and New Discovery Platform

Never miss stories about

Oncology

International Consortium Publishes 665 Validated Patient-Derived Cancer Models

XJ-4-85 Forces Metabolic Collapse in Tumors

Scientists Identify TRNAU1AP Pathway That Sustains Glioblastoma Stem Cells

Inherited Genes Steer Tumour Evolution, Mouse Study Shows

Germline Genetic Variants Shape Safety and Activity of CAR‑T Therapy

NTX-301 Reprograms Epigenetics to Fight Treatment-Resistant AML

Low-Frequency Ultrasound Selectively Kills Oral Cancer Cells

CAR‑T Cells Targeting GPNMB Eradicate Glioblastoma in Preclinical Models

Algae-Based Microrobots Greatly Increase Chemotherapy Delivery to Bladder Tumors

Fibroblasts Explain Why Lung Cancer Subtypes Respond Differently to Anti‑Angiogenic Drugs

Never miss stories about

Oncology